Name | Title | Contact Details |
---|---|---|
Ken Thompson |
Director Infrastructure, Service and Information Security | Profile |
We are a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions. We believe that serlopitant, a highly selective small molecule inhibitor of the neurokinin 1 receptor, or NK1R, given as a once daily, oral tablet, has the potential to significantly alleviate pruritus associated with various conditions.
Occupational Environmental Health Solutions is a Chatham, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Chicago Hospital Risk Pooling Program is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
RECKITT BENCKISER NORTH AMERICA is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Life Support Technologies Group is a Valhalla, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.